GSK : NYSE
Industry: Pharmaceuticals

Balance Sheet
2008
12/31/08
2007
12/31/07
2006
12/31/06
2005
12/31/05
Cash8,2096,7043,9247,232
Short Term Investments1,8203,2302,0251,761
ASSETS
Cash & Short Term Investments10,0299,9355,9498,993
Receivables - Net8,82610,54410,3319,412
Raw Materials1,6452,1921,4951,239
Work in Progress1,8911,5301,225948
Finished Goods2,3852,3532,0491,553
Inventories - Total5,9216,0754,7693,741
Prepaid Expenses12----
Other Current Assets432480462495
CURRENT ASSETS - TOTAL25,21027,03621,51122,641
Buildings7,9718,3537,8347,072
Machinery & Equipment15,48816,50214,70313,289
Property, Plant, & Equipment under Capitalized Leases8701,198986546
Property, Plant and Equipment - Gross27,71829,93526,30722,663
Accumulated Depreciation(13,590)(14,417)(12,746)(11,234)
Property, Plant and Equipment - Net14,12815,51813,56211,430
Long Term Receivables788857840753
Investments in Associated Companies806653577474
Other Investments8541,0281,084622
Deferred Charges575063500
Total Intangible Other Assets - Net11,63511,5607,9287,009
Other Assets - Total15,72116,42312,43310,813
TOTAL ASSETS53,47957,15745,85142,928
LIABILITIES
Accounts Payable1,6831,8471,6931,407
Short Term Debt & Current Portion of Long Term Debt1,3966,9521,4052,062
Income Taxes Payable1,1391,6391,2153,899
Dividends Payable----1410
Other Current Liabilities10,40610,0879,8908,964
CURRENT LIABILITIES - TOTAL14,62320,52614,21716,342
Capitalized Lease Obligations128165190143
Long Term Debt22,23514,0229,3399,057
Provision for Risks and Charges6,8384,7985,6116,546
Deferred Income140135190100
Deferred Taxes - Credit1,0421,7601,164978
Deferred Taxes - Debit4,0294,3574,1553,804
DEFERRED TAXES(2,987)(2,597)(2,990)(2,826)
Other Liabilities486611605703
TOTAL LIABILITIES41,33637,49426,97129,921
EQUITY
Non-Equity Reserves0000
Minority Interest565609513445
Preferred Stock0000
Common Stock2,0662,9822,9322,562
Capital Surplus1,9362,5121,679943
Other Appropriated Reserves255169159139
Unappropriated (Free) Reserves(12)669832624
Retained Earnings9,44715,94416,68512,268
ESOP Guarantees2,1093,2083,9123,974
Unrealized Foreign Exchange Gain/Loss(4)(14)(6)--
COMMON EQUITY11,57819,05418,36812,562
TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY53,47957,15745,85142,928
SHARE INFORMATION
Common Shares Outstanding2,5942,7542,8782,910
2009 Q3
9/30/09
2009 Q2
6/30/09
2009 Q1
3/31/09
2008 Q4
12/31/08
2008 Q3
9/30/08
Cash------8,209--
ASSETS
Cash & Short Term Investments11,2469,7519,73410,02910,495
Receivables - Net9,7638,9268,5568,8269,845
Inventories - Total6,7096,4425,8425,9216,254
Prepaid Expenses------1--
Other Current Assets273343214
CURRENT ASSETS - TOTAL27,74625,12224,13525,21026,609
Property, Plant and Equipment - Gross------27,718--
Accumulated Depreciation------(13,590)--
Property, Plant and Equipment - Net15,00814,62113,43014,12814,938
Investments in Associated Companies818738710806792
Total Intangible Other Assets - Net16,88812,85311,81211,63511,906
Other Assets - Total22,74418,76317,44017,36317,911
TOTAL ASSETS62,48055,01051,77153,47955,909
LIABILITIES
Accounts Payable------1,683--
Short Term Debt & Current Portion of Long Term Debt3,0181,9521,8151,3962,468
Income Taxes Payable1,8861,4421,3491,1391,883
Other Current Liabilities12,88811,48910,70010,40611,304
CURRENT LIABILITIES - TOTAL17,79214,88313,86314,62315,655
Capitalized Lease Obligations------128--
Long Term Debt24,05621,52721,48822,23522,778
Deferred Taxes - Credit1,1068191,0201,0421,160
Deferred Taxes - Debit3,8354,2343,9434,0294,340
DEFERRED TAXES(2,730)(3,415)(2,923)(2,987)(3,180)
Other Liabilities7,9478,7847,3467,4646,783
TOTAL LIABILITIES47,06641,77939,77441,33642,036
EQUITY
Non-Equity Reserves00000
Minority Interest566517529565553
Preferred Stock00000
Common Stock2,2662,3332,0142,0662,532
Capital Surplus2,1502,2091,9061,9362,352
Retained Earnings9,1227,0136,5709,4477,294
Unrealized Foreign Exchange Gain/Loss------(4)--
COMMON EQUITY14,84812,71311,46811,57813,320
TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY62,48055,01051,77153,47955,909
SHARE INFORMATION
Common Shares Outstanding2,5942,5942,594--2,544
() = Negative Values
Values are displayed in Millions except for earnings per share and where noted